Amir Nashat
CIK 1575843 · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$96.54M
Companies
10
Total Filings
82
Lifetime Open-Market Net
-$16.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAMP | Director | 197,661 | $4.65 | $919.1K | $12.00M | 4 | 2026-06-12 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 130,298 | $56.99 | $7.43M | -$8.69M | 9 | 2024-06-05 |
| SRRK | Director | 1,689,555 | $56.51 | $95.48M | $7.87M | 13 | 2024-05-13 |
| Metacrine, Inc. (MTCR) Delisted | Director | 2,499,210 | $0.49 | $1.24M | $2.99M | 3 | 2022-09-06 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Director | 2,217 | $0.00 | $1 | $5.00M | 9 | 2022-06-02 |
| FATE | Director | 11,333 | $2.65 | $30.0K | -$17.96M | 21 | 2019-08-02 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 52,156 | $0.88 | $46.0K | -$1.92M | 8 | 2019-06-18 |
| LIFE | Director | 3,354 | $32.85 | $110.2K | $0 | 6 | 2018-05-17 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 1 | 2015-06-10 |
| Receptos, Inc. (RCPT) Delisted | Director | 46,923 | — | — | -$15.80M | 7 | 2013-12-10 |
Recent Filings · Page 8 of 9
82 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-10 | DNIB UNWIND, INC. (BIND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-18 | FATE | Grant (A) | — | $0 | EDGAR |
| 2015-05-15 | FATE | Grant (A) | — | $0 | EDGAR |
| 2015-05-14 | LIFE | Conv (C) | +1,827,992 | $0 | EDGAR |
| 2013-12-10 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −170,000 | -$4.54M | EDGAR |
| 2013-11-22 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −169,315 | -$4.23M | EDGAR |
| 2013-11-22 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −30,685 | -$698.7K | EDGAR |
| 2013-11-19 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −169,315 | -$4.23M | EDGAR |
| 2013-11-18 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −169,315 | -$4.23M | EDGAR |
| 2013-10-07 | FATE | Mixed | +2,473,186 | $5.77M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.